Trade union Unite calls for GSK staff walkouts over pay increase disputes

April 20, 2023
Manufacturing and Production

UK-based trade union Unite is pushing for staff walkouts at several GSK manufacturing sites due to disputes regarding pay increases. …

christina-victoria-craft-zhys6xn7sue-unsplash_5

PANTHERx Rare announces release of treatment for rare stable Wilson Disease

April 20, 2023
Sales and Marketing

US-based rare medicines pharmacy PANTHERx Rare has announced the launch of Cuvrior, a treatment for stable Wilson Disease in adults …

Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery

April 19, 2023
Business Services

New York, April 19, 2023 – Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that …

Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality

April 19, 2023
Business Services

BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in …

Growth in global demand for pure medical cannabis sees Lesotho-based cultivator and manufacturer expand its production

April 19, 2023
Business Services

19 April 2023, Maseru – Licensed cultivator and manufacturer of medical-grade cannabis extracts and products,

Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis

April 19, 2023
Business Services

NEW ORLEANS and CAMBRIDGE, UK, April 19 2023 – Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that …

lars_nieba_002

Engimmune Therapeutics appoints Dr. Lars Nieba as Chief Executive Officer

April 19, 2023
Business Services

Basel, Switzerland, April 19, 2023. Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today …

milad-fakurian-58z17lnvs4u-unsplash_2

Acadia Pharmaceuticals announces commercialisation of Daybue for Rett syndrome

April 19, 2023
Sales and Marketing

Acadia Pharmaceuticals has announced that Daybue (trofinetide) is now available for adult and paediatric patients over the age of two …

louis-reed-pwckf7l4-no-unsplash_5

ANGLE and BioView partner to develop a CTC-based HER2 assay

April 19, 2023
Medical Communications

ANGLE, a liquid biopsy company, and BioView, a company developing, manufacturing and marketing automated microscopy imaging and analysis solutions, have …

mat-napo-qqyix177sy0-unsplash

FDA issues update around changes to COVID-19 vaccines’ EUAs

April 19, 2023
Medical Communications

The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA …

robina-weermeijer-ihfopazzjhm-unsplash_5

Neuspera Medical receives FDA approval for peripheral nerve pain system

April 19, 2023
Medical Communications

Medical device company Neuspera Medical has announced that it has received FDA approval for its implantable system, used to treat …

OWEN MUMFORD WINS DISTINCTION IN RED DOT AWARD (PRODUCT DESIGN 2023) FOR AIDAPTUS® AUTO-INJECTOR

April 18, 2023
Business Services

OXFORD, England, 18 April 2023 – Owen Mumford is proud to have been awarded a distinction in the prestigious Red …

Pneumagen further strengthens IP protection for lead product Neumifil with granting of US composition of matter patent

April 18, 2023
Business Services

St Andrews, UK – 18 April 2023 – Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal …

NeoPhore signs research collaboration with The Institute of Cancer Research, London

April 18, 2023
Business Services

London, UK, 18 April 2023, – NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces that it has signed a …

New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023

April 18, 2023
Business Services

Strasbourg, France & Tokyo, Japan, April 18, 2023, 9:00 a.m. CET/4:00 p.m. JST – Transgene (Euronext Paris: TNG), a biotech company …

Nouscom Presents New Positive Translational Phase 1b Data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy, in a Late-Breaking Abstract at AACR 2023

April 18, 2023
Business Services

BASEL, Switzerland – 18th April 2023 – Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector immunotherapies, …

MED3000, Eroxon® UK Launch

April 18, 2023
Business Services

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on …

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting

April 18, 2023
Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces it …

GSK enters into £1.6bn deal to acquire Bellus Health

April 18, 2023
Medical Communications

UK-based GSK has announced its plans to acquire Bellus Health, a Canadian late-stage biopharmaceutical company which focuses on treatments for …

The Gateway to Local Adoption Series

Latest content